61/8008/2026 - Exceptional Use Authorization of the Medication
About This Opportunity
TranslatedThe tender 61/8008/2026 pertains to the Exceptional Use Authorization of a specific medication. This authorization allows for the use of a medication that may not typically be available under standard regulations, indicating a need for flexibility in its application due to unique circumstances. The tender outlines the procedures and criteria for obtaining this authorization, which is crucial for healthcare providers seeking to administer the medication in question. Key requirements may include documentation of the medical necessity, evidence of the medication's efficacy, and adherence to safety protocols. The location for the tender is not specified, but it is likely to be relevant to healthcare institutions or professionals operating within the jurisdiction that governs this authorization. This tender is significant within the healthcare sector, particularly for those involved in pharmaceutical procurement and patient care management, as it addresses urgent medical needs that require immediate attention. Stakeholders interested in this tender should ensure they meet all outlined criteria and prepare the necessary documentation to facilitate the authorization process efficiently.
This is a supplies contract in the health and medical services, Monitoring Evaluation and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 9,034.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "61/8008/2026 - Autorização de Utilização Excecional do Medicamento" pertains to the exceptional authorization for the use of a specific medication in Portugal.
This procurement process is issued by a relevant contracting authority within the Portuguese healthcare sector, aimed at facilitating the expedited approval of medicinal products that may not yet be fully authorized for general use but are deemed necessary for public health under specific circumstances.
In this context, the tender seeks to identify suppliers or pharmaceutical companies capable of providing the required medication following the guidelines set forth by the Portuguese health authorities. The exceptional authorization process is crucial for ensuring that patients have access to potentially life-saving treatments while still adhering to regulatory standards.
Typical requirements for such tenders may include comprehensive documentation demonstrating the safety and efficacy of the medication, adherence to Good Manufacturing Practices (GMP), and the ability to supply the product within a specified timeframe. Additionally, bidders may need to present a detailed plan for monitoring the medication's usage and reporting any adverse effects during the authorization period.
Prospective bidders should be prepared to engage in a thorough evaluation process to ensure compliance with both national and European regulations governing pharmaceutical products. The tender is an important step in enhancing healthcare delivery in Portugal, reflecting the nation's commitment to providing timely access to innovative medical solutions in response to urgent public health needs.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 18, 2026. Last refreshed 9 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Algarve, EPE
Unidade Local de Saúde do Algarve, EPE has issued 858 procurement notices on BidsFactory, including 12 currently open and 804 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Industry & Manufacturing. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to INOVEMED – PRODUTOS FARMACEUTICOS. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Algarve, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €9,034. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.